Follicular Lymphoma Foundation
David Kennard is a highly experienced biotechnology consultant and entrepreneur, currently serving as the Founder & Principal of Cres Associates since 2003. Kennard holds multiple advisory roles, including Royal Society Entrepreneur in Residence at MRC Laboratory of Medical Sciences, Senior Commercial Advisor at Closed Loop Medicine, and Industry Advisor for the Follicular Lymphoma Foundation. Previously, Kennard contributed to Cancer Research UK as a Senior Advisor and held key positions at Gilead Sciences and YM BioSciences, among others. Educational qualifications include a Doctor of Philosophy in Biochemistry and a Master of Business Administration.
This person is not in any teams
Follicular Lymphoma Foundation
The Follicular Lymphoma Foundation is the first organisation in the world dedicated solely to finding new treatments and cures for follicular lymphoma. Follicular lymphoma is a currently incurable blood cancer. The FLF was founded by Nicola Mendelsohn three years after her diagnosis with the disease and is focused on funding and facilitating work that will take new treatments and cures for the disease from bench to bedside in the quickest possible timeframe. We are doing this by disrupting and challenging the current thinking on how to find a cure for this disease, by mobilising patients and investing in the most promising scientific and research discovery approaches.